ACHV
Price
$6.50
Change
-$0.01 (-0.15%)
Updated
Oct 22 closing price
Capitalization
668.87M
14 days until earnings call
Intraday BUY SELL Signals
AVXL
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
126.07M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs AVXL

ACHV vs AVXL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACHV vs. AVXL commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and AVXL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACHV with price predictions
Oct 22, 2026

ACHV in downward trend: 10-day moving average broke below 50-day moving average on October 08, 2026

The 10-day moving average for ACHV crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACHV as a result. In 60 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

ACHV moved below its 50-day moving average on October 02, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for ACHV entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACHV's RSI Indicator exited the oversold zone, 30 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHV advanced for three days, in 212 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

ACHV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-45.576) is normal, around the industry mean (2.973). P/E Ratio (-3.916) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ACHV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for AVXL with price predictions
Oct 22, 2026

AVXL sees its Stochastic Oscillator climbs out of oversold territory

On October 21, 2026, the Stochastic Oscillator for AVXL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 52 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for AVXL just turned positive on October 21, 2026. Looking at past instances where AVXL's MACD turned positive, the stock continued to rise in 33 of 42 cases over the following month. The odds of a continued upward trend are 79%.

AVXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for AVXL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.121) is normal, around the industry mean (2.973). P/E Ratio (-9.714) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. AVXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ACHV vs AVXL: Fundamental Ratings
ACHV
AVXL
OUTLOOK RATING
1..100
773
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
4494
P/E GROWTH RATING
1..100
4611
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (4) in the Biotechnology industry is in the same range as AVXL (16). This means that ACHV’s stock grew similarly to AVXL’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVXL (100). This means that ACHV’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's SMR Rating (94) in the Biotechnology industry is in the same range as ACHV (100). This means that AVXL’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for AVXL (94). This means that ACHV’s stock grew somewhat faster than AVXL’s over the last 12 months.

AVXL's P/E Growth Rating (11) in the Biotechnology industry is somewhat better than the same rating for ACHV (46). This means that AVXL’s stock grew somewhat faster than ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVAVXL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ACHV: $6.50 vs. AVXL: $1.36)
Brand notoriety: ACHV and AVXL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 53% vs. AVXL: 106%
Market capitalization -- ACHV: $668.87M vs. AVXL: $126.07M
ACHV [@Biotechnology] is valued at $668.87M. AVXL’s [@Biotechnology] market capitalization is $126.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 1 FA rating(s) are green while AVXL’s FA Score has 2 green FA rating(s).

  • ACHV’s FA Score: 1 green, 4 red.
  • AVXL’s FA Score: 2 green, 3 red.
According to our system of comparison, ACHV is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while AVXL’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • AVXL’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -6.74% price change this week, while AVXL (@Biotechnology) price change was -8.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 05, 2026.

AVXL is expected to report earnings on Nov 24, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACHV
Daily Signal:
Gain/Loss:
AVXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with RANI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then RANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-0.15%
RANI - ACHV
42%
Loosely correlated
-2.88%
BEAM - ACHV
36%
Loosely correlated
-1.13%
OGEN - ACHV
35%
Loosely correlated
-1.82%
AVXL - ACHV
34%
Loosely correlated
N/A
RNAC - ACHV
33%
Loosely correlated
-0.16%
More

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with TENX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
N/A
TENX - AVXL
47%
Loosely correlated
+7.98%
AXON - AVXL
45%
Loosely correlated
+2.98%
MAZE - AVXL
45%
Loosely correlated
-1.93%
VCYT - AVXL
41%
Loosely correlated
-0.39%
ARRY - AVXL
41%
Loosely correlated
-3.23%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QSU3.020.18
+6.34%
Defiance Daily Target 2X Long QS ETF (QSU)
FXED16.640.24
+1.49%
Sound Enhanced Fixed Income ETF (FXED)
PCPI50.510.03
+0.07%
PIMCO Inflation PLUS Active ETF (PCPI)
GDEC40.95-0.19
-0.45%
FT Vest U.S. Equity Moderate Buffer ETF - December (GDEC)
FENY36.99-0.38
-1.02%
Fidelity MSCI Energy Index ETF (FENY)